Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
EMBED
1 other identifier
interventional
1,200
1 country
1
Brief Summary
Measurement-based care (MBC) is an evidence-based practice that incorporates routine outcome assessment using validated rating scales to guide collaborative clinical decision-making. Although MBC results in improved outcomes for patients with major depressive disorder (MDD), there are barriers to its broad implementation in clinical settings. The use of "enhanced" MBC (eMBC), with mobile apps that allow patients to track outcomes and engage in self-management via WeChat, may address some of these barriers. The investigators hypothesize that implementation with eMBC using WeChat will be superior to standard MBC implementation using paper-pencil assessments at the clinic, for both implementation and clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Sep 2022
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2022
CompletedStudy Start
First participant enrolled
September 3, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedSeptember 21, 2022
July 1, 2022
4 months
August 11, 2022
September 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Health Questionnaire-9 (PHQ-9)
To evaluate the severity of depressive symptoms by patients. Remission: total score ≤ 4.
up to 6 months
Proportion of patients with a Patient Health Questionnaire-9 (PHQ-9) score
Proportion of patients with a PHQ-9 score entered in the clinical record.
up to 6 months
Secondary Outcomes (11)
Patient Health Questionnaire-9(PHQ-9) change scores
up to 6 months
The Sheehan disability scale (SDS)
up to 6 months
Quality of Life scale (QOL-6)
up to 6 months
EuroQoL 5 Dimensions (EQ-5D)
up to 6 months
Health economic assessment (HEA)
up to 6 months
- +6 more secondary outcomes
Study Arms (2)
Enhanced MBC Implementation(eMBC)
EXPERIMENTALThe eMBC implementation arm use our WeChat Easy to Recover from Depression Mini-Program, which consists of mood tracking and lay-coached self-management.
Standard MBC Implementation
ACTIVE COMPARATORThe standard MBC implementation arm use paper and pencil questionnaires.
Interventions
The experimental group will implement eMBC with our WeChat Easy to Recover from Depression Mini-Program, which consists of mood tracking and lay-coached self-management.
The control intervention group will implement standard MBC using paper and pencil questionnaires.
Eligibility Criteria
You may qualify if:
- Men or women aged 18-65 years;
- Participants were diagnosed of unipolar depressive disorder by the treating physician based on accepted diagnostic criteria (e.g., CCMD-3, DSM-IV, DSM-5, ICD-10);
- Participants are expected to have a smartphone device available and be proficient in using a smartphone;
- Participants should have a junior high school education or above, have sufficient audio-visual skills, be able to fully understand the research content and have the legal ability to sign informed consent.
You may not qualify if:
- Presence of obvious violent aggressive behavior or tendencies;
- Participants who are unstable during onset episodes and cannot cooperate in completing the study content;
- Serious suicidal tendencies;
- Inability to carry out effective verbal communication;
- No smartphone;
- Other circumstances that prevented cooperation or completion of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai Mental Health Centerlead
- University of British Columbiacollaborator
- University of Torontocollaborator
- University of Melbournecollaborator
- Boston Universitycollaborator
- University of Californiacollaborator
- University of Albertacollaborator
- Shanghai CDC for Mental Healthcollaborator
- Institute of Population Research, Peking Universitycollaborator
- University of Michigancollaborator
- Queen's Universitycollaborator
- Hongkou Mental Health Centercollaborator
Study Sites (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
Related Publications (1)
Lam RW, Michalak EE, Murphy JK, Colquhoun H, Ng C, Culpepper L, Dewa CS, Greenshaw AJ, He Y, Kennedy SH, Li X, Liu J, Liu T, Parikh S, Soares CN, Wang Z, Xu Y, Chen J. Standard Versus Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): Protocol for a Cluster Randomized Implementation-Effectiveness Trial. Cureus. 2025 Aug 18;17(8):e90395. doi: 10.7759/cureus.90395. eCollection 2025 Aug.
PMID: 40970017DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Chen, M.D., Ph.D
Shanghai Mental Health Center(SMHC)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2022
First Posted
September 6, 2022
Study Start
September 3, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
September 21, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share